InvestorsHub Logo
Followers 51
Posts 3946
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Monday, 12/18/2017 11:10:39 AM

Monday, December 18, 2017 11:10:39 AM

Post# of 462231
The hard part is knowing what you want. Biogen wanted a look at 2-73, why wouldn’t they want it? If they wanted it why haven’t they done something about it? With everything else that’s going on with 2-73 there doesn’t seem to be any downsides. So, what does Biogen want?

What does Pfizer want?

Are we on their shopping lists?

That would explain why Biogen hasn’t done anything with us and M isn’t forthcoming with any info. They can read the writing on the wall. It will be cheaper to acquire Anavex than compete with it.

Maybe the manipulation is to get shares for a possible takeover or delay price increases to reduce acquisition costs? Every day Anavex gets closer to starting a trial the acquisition cost goes up. Would it be safe to say, someone doesn’t want us to hit our stride?

Could be a lump of cash and a big stocking stuffer.

imo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News